News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
568,270 Results
Type
Article (33039)
Company Profile (86)
Press Release (535135)
Multimedia
Podcasts (134)
Webinars (25)
Section
Business (163475)
Career Advice (1922)
Deals (26580)
Drug Delivery (91)
Drug Development (66815)
Employer Resources (122)
FDA (13557)
Job Trends (11409)
News (274834)
Policy (24670)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2181)
Academic (2)
Accelerated approval (30)
Adcomms (19)
Allergies (136)
Alliances (42837)
ALS (175)
Alzheimer's disease (1507)
Antibody-drug conjugate (ADC) (349)
Approvals (13952)
Artificial intelligence (583)
Autoimmune disease (216)
Automation (45)
Bankruptcy (222)
Best Places to Work (9400)
BIOSECURE Act (17)
Biosimilars (165)
Biotechnology (62)
Bladder cancer (165)
Brain cancer (57)
Breast cancer (643)
Cancer (4914)
Cardiovascular disease (397)
Career advice (1646)
Career pathing (41)
CAR-T (258)
CDC (38)
Celiac Disease (1)
Cell therapy (732)
Cervical cancer (36)
Clinical research (58336)
Collaboration (1839)
Company closure (4)
Compensation (818)
Complete response letters (49)
COVID-19 (2034)
CRISPR (89)
C-suite (891)
Cystic fibrosis (125)
Data (6699)
Decentralized trials (3)
Denatured (47)
Depression (124)
Dermatology (48)
Diabetes (499)
Diagnostics (5470)
Digital health (47)
Diversity (9)
Diversity, equity & inclusion (38)
Drug discovery (297)
Drug pricing (148)
Drug shortages (24)
Duchenne muscular dystrophy (225)
Earnings (70263)
Editorial (56)
Employer branding (16)
Employer resources (112)
Events (90303)
Executive appointments (971)
FDA (16692)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (10)
Frontotemporal dementia (27)
Funding (1474)
Gene editing (181)
Generative AI (58)
Gene therapy (588)
GLP-1 (823)
Government (3419)
Grass and pollen (6)
Guidances (372)
Healthcare (15010)
HIV (66)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (216)
Immuno-oncology (77)
Indications (149)
Infectious disease (2293)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (247)
Interviews (357)
IPO (13098)
IRA (42)
Job creations (2374)
Job search strategy (1360)
JPM (56)
Kidney cancer (12)
Labor market (66)
Layoffs (385)
Leadership (35)
Legal (5823)
Liver cancer (80)
Longevity (21)
Lung cancer (672)
Lymphoma (392)
Machine learning (45)
Management (40)
Manufacturing (788)
MASH (162)
Medical device (10579)
Medtech (10641)
Mergers & acquisitions (14624)
Metabolic disorders (1204)
mRNA (133)
Multiple sclerosis (160)
NASH (13)
Neurodegenerative disease (346)
Neuropsychiatric disorders (80)
Neuroscience (2761)
NextGen: Class of 2026 (4974)
Non-profit (3659)
Now hiring (34)
Obesity (526)
Opinion (269)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (224)
Parkinson's disease (323)
Partnered (28)
Patents (470)
Patient recruitment (535)
Peanut (46)
People (49419)
Pharmaceutical (21)
Pharmacy benefit managers (23)
Phase 1 (18070)
Phase 2 (25377)
Phase 3 (19574)
Pipeline (6641)
Policy (236)
Postmarket research (2306)
Preclinical (7787)
Press Release (58)
Prostate cancer (265)
Psychedelics (33)
Radiopharmaceuticals (265)
Rare diseases (860)
Real estate (4017)
Recruiting (51)
Regulatory (19592)
Reports (38)
Research institute (2102)
Resumes & cover letters (292)
Rett syndrome (32)
RNA editing (12)
RSV (70)
Schizophrenia (149)
Series A (252)
Series B (176)
Service/supplier (5)
Sickle cell disease (90)
Special edition (19)
Spinal muscular atrophy (135)
Sponsored (38)
Startups (2709)
State (1)
Stomach cancer (12)
Supply chain (90)
Tariffs (59)
The Weekly (86)
Vaccines (873)
Venture capital (73)
Weight loss (318)
Women's health (83)
Worklife (17)
Date
Last 7 days (580)
Last 30 days (2313)
Last 365 days (27084)
2026 (7247)
2025 (27338)
2024 (29858)
2023 (32902)
2022 (42261)
2021 (45377)
2020 (42971)
2019 (36937)
2018 (27731)
2017 (25968)
2016 (24868)
2015 (29074)
2014 (23452)
2013 (20125)
2012 (20534)
2011 (20801)
2010 (19533)
Location
Africa (678)
Alabama (92)
Alaska (6)
Arizona (220)
Arkansas (12)
Asia (33185)
Australia (5192)
California (11001)
Canada (2862)
China (1119)
Colorado (456)
Connecticut (493)
Delaware (355)
Europe (75763)
Florida (1534)
Georgia (349)
Hawaii (3)
Idaho (43)
Illinois (851)
India (77)
Indiana (485)
Iowa (22)
Japan (465)
Kansas (106)
Kentucky (33)
Louisiana (30)
Maine (77)
Maryland (1290)
Massachusetts (7939)
Michigan (308)
Minnesota (523)
Mississippi (6)
Missouri (109)
Montana (29)
Nebraska (25)
Nevada (125)
New Hampshire (56)
New Jersey (3091)
New Mexico (26)
New York (2895)
North Carolina (1358)
North Dakota (10)
Northern California (5403)
Ohio (309)
Oklahoma (21)
Oregon (34)
Pennsylvania (2140)
Puerto Rico (13)
Rhode Island (48)
South America (956)
South Carolina (53)
South Dakota (1)
Southern California (4385)
Tennessee (188)
Texas (1785)
United States (38742)
Utah (316)
Vermont (1)
Virginia (273)
Washington D.C. (77)
Washington State (860)
West Virginia (3)
Wisconsin (124)
Wyoming (2)
568,270 Results for "r and d lifesciences llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all that cash went at companies like Johnson & Johnson, Amgen and Pfizer.
March 25, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Immunocore announces R&D leadership evolution
February 1, 2026
·
6 min read
Rare diseases
Cashing In on ‘Creative Fundamentals’ To Fund Rare Disease R&D
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations. Initiatives like the Orphan Therapeutics Accelerator are attempting to solve what CEO Craig Martin says is not a science problem, but a math problem.
February 25, 2026
·
7 min read
·
Heather McKenzie
Press Releases
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
March 16, 2026
·
5 min read
Press Releases
Mosaic Therapeutics appoints Dr Vince O’Neill, MD, as Head of R&D
April 1, 2026
·
2 min read
Press Releases
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
March 12, 2026
·
5 min read
Press Releases
Henriette Mersebach to step down as ALK’s head of R&D
February 20, 2026
·
2 min read
Press Releases
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting
March 18, 2026
·
11 min read
Press Releases
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
March 19, 2026
·
10 min read
Press Releases
Integra LifeSciences Announces Key Executive Leadership Appointments
February 17, 2026
·
5 min read
Previous
2 of 56,827
Next
